Patients' quality of life after allogeneic haematopoietic stem cell transplantation: mixed-methods study

Allogeneic haematopoietic stem cell transplantation (HSCT) is an increasingly widespread therapy method. It is associated with many socio-psychological and physical risks. Forty-four subjects, who were clinically monitored at the Bolzano BMT Centre including a follow-up period of at least 3 months, completed the questionnaire Functional Assessment of Chronic Illness Therapy-Bone Marrow Transplantation (version 4). Semi-structured, problem-oriented interviews were conducted with seven randomly selected subjects, the results of which were subjected to a summarising content analysis according to Mayring. The results from the quantitative and qualitative parts were compared based on triangulation. In the random sample, 22.7% stated that they were highly satisfied with their current quality of life (QOL). Throughout all dimensions of the questionnaire, women showed lower scores than men. The results revealed a positive correlation between the post-HSCT period and QOL (r(s)=0.338, P=0.025), especially regarding the social/family (r(s)=0.411, P=0.006) and emotional well-being (r(s)=0.306, P=0.043). The interviews primarily revealed dependence and inability to work. The support received from family, friends and hospital staff and the shift in priorities because of the transplantation were perceived as positive. The comparison mainly leads to corresponding results of the quantitative and qualitative parts of the study. Patient self-rating using questionnaires and interviews plays a direct and relevant role in the assessment of the QOL after allogeneic HSCT.